老年人群内移性喉成形术的多机构评估
本研究回顾性分析两家三级学术医疗中心2008年1月至2016年5月136例65岁及以上接受内移性喉成形术患者的病历,评估嗓音、吞咽结局及并发症。术后总GRBAS与VHI-10评分显著改善(P<.05),81.6%患者改善≥20%,53.7%改善≥50%;无重大并发症,轻微并发症发生率5.9%。多变量logistic回归显示术前注射增容是VHI-10改善较少的独立预测因素(P=.015)。
要点
- 老年患者内移性喉成形术后总GRBAS与VHI-10评分显著改善(P<.05)。
- 81.6%患者VHI-10改善≥20%,53.7%改善≥50%;轻微并发症发生率5.9%,无重大并发症。
- 术前注射增容是VHI-10改善较少的独立预测因素(P=.015)。
核心结论
- 老年患者内移性喉成形术后患者与提供者感知的嗓音质量显著改善,且即使在该老年队列中并发症发生率也低。
- 术前注射增容的患者在内移性喉成形术后患者感知的嗓音结局改善减弱。
研究设计与样本
- 采用病历回顾的病例系列研究,纳入两家三级学术医疗中心2008年1月至2016年5月136例65岁及以上接受内移性喉成形术的患者。
主要发现
- 术后总GRBAS与VHI-10评分显著改善(P<.05)。
- 81.6%患者改善≥20%,53.7%患者改善≥50%。
- 无患者发生重大并发症,5.9%患者发生轻微并发症。
- 多变量logistic回归显示术前注射增容是VHI-10评分改善较少的独立预测因素(P=.015)。
- 内移性喉成形术前的嗓音治疗不影响嗓音结局(P=.640)。
关键数值与推荐
- 术后总GRBAS与VHI-10评分显著改善(P<.05)。
- 81.6%患者VHI-10改善≥20%,53.7%患者改善≥50%。
- 轻微并发症发生率5.9%,无重大并发症。
- 术前注射增容预测VHI-10改善较少(P=.015);术前嗓音治疗对嗓音结局无影响(P=.640)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate voice outcomes of medialization laryngoplasty in the elderly population (65 years and older) and to identify swallow outcomes, complication rates, and predictors of voice outcomes. STUDY DESIGN: Case series with chart review. SETTING: Two tertiary academic medical centers. SUBJECTS AND METHODS: We retrospectively reviewed charts of 136 patients age 65 years and older undergoing medialization laryngoplasty between January 2008 and May 2016 at 2 tertiary academic institutions. Primary outcome was assessed using Voice Handicap Index 10 (VHI-10) score and Grade, Roughness, Breathiness, Asthenia, and Strain (GRBAS) score. Secondary outcomes were assessed using the Eating Assessment Tool 10 (EAT-10) when dysphagia was present, stroboscopic analysis of glottic closure, and complication rates. A logistic regression analysis assessed predictors of voice improvement after medialization laryngoplasty. RESULTS: Total GRBAS and VHI-10 scores showed a significant improvement postoperatively ( P < .05). A ≥20% improvement was seen in 81.6% of patients, and a ≥50% improvement was seen in 53.7%. No patient had major complications. Minor complications occurred in 5.9% of patients. Multivariable logistic regression identified preoperative injection augmentation as an independent predictor of less improvement in VHI-10 score ( P = .015). Voice therapy prior to medialization did not affect voice outcomes ( P = .640). CONCLUSION: Patient- and provider-perceived voice quality are significantly improved after medialization laryngoplasty in the elderly, and the procedure is associated with a low complication rate even in an elderly cohort. Improvement in patient-perceived voice outcomes after medialization laryngoplasty was diminished in patients with preoperative injection augmentation.
引用
- Philips R, Chorath K, DeSilva B, et al. Multi-institutional Evaluation of Medialization Laryngoplasty in the Elderly. Otolaryngol Head Neck Surg. 2018. PMID: 30526322. doi:10.1177/0194599818817762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。